Anti-Angiogenesis and Disintegrins

作者: Stephen Swenson , Radu Minea , Samuel Zidovetzki , Corey Helchowski , Fritz Costa

DOI: 10.1007/978-90-481-9295-3_19

关键词:

摘要: Angiogenesis is a critical process in tumor and disease progression. A number of features are central to both growth development, the recruitment invasion growing vascular network supplying with nutrients mechanism escape allow meastatic growth. One class molecules important blood vessel family cell surface receptors identified as integrins. Integrins α/β heterodimeric glycoproteins which different α subunits combine distinct β resulting range specificities toward various extracellular matrix (ECM) proteins. The RGD sequence found ECM proteins recognized by several classes integrins, allowing for linkage cytoskeletal associated integrins leads involvement bi-directional signaling that displays profound effects on cellular functions. Among these integrin mediated interactions adhesion endothelial cells cancer proteins, an interaction integral metastasis, angiogensis. Antibodies targeted have been shown retard subsequent induced angiogenesis. concern this approach antibody targets single integrin, may utilize other non-targeted circumvent type blockage. more broad spectrum agent available binds blocks function at time, agents disintegrin. Originally purified from venom Viperidae snakes, disintegrins role nature presumably block platelet aggregation following envenomation based activated It has observed overexpressed some types angiogenic vasculature similar affinity motifs Based disintegrin structure we developed recombinant form snake disintegrin, call vicrostatin (VCN). VCN potent anti-angiogenic/anti-tumor vitro vivo laboratory studies. Further development derived along new technology looking additional disintegrin-like offer novel therapeutic targeting

参考文章(97)
John D Hood, Mark Bednarski, Ricardo Frausto, Samira Guccione, Ralph A Reisfeld, Rong Xiang, David A Cheresh, Tumor Regression by Targeted Gene Delivery to the Neovasculature Science. ,vol. 296, pp. 2404- 2407 ,(2002) , 10.1126/SCIENCE.1070200
Vladislav Golubkov, Debra Hawes, Francis S. Markland, Anti-Angiogenic Activity of Contortrostatin, a Disintegrin from Agkistrodon Contortrix Contortrix Snake Venom Angiogenesis. ,vol. 6, pp. 213- 224 ,(2003) , 10.1023/B:AGEN.0000021396.47009.B0
Kathleen W. Beekman, Maha Hussain, Targeted approaches for the management of metastatic prostate cancer Current Oncology Reports. ,vol. 8, pp. 206- 212 ,(2006) , 10.1007/S11912-006-0021-9
Oliver Stoeltzing, Wenbiao Liu, Niels Reinmuth, Fan Fan, Graham C. Parry, Alexander A. Parikh, Marya F. McCarty, Corazon D. Bucana, Andrew P. Mazar, Lee M. Ellis, Inhibition of integrin α5β1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice International Journal of Cancer. ,vol. 104, pp. 496- 503 ,(2003) , 10.1002/IJC.10958
Francis S. Markland, Kate Shieh, Qing Zhou, Vladislav Golubkov, Russell P. Sherwin, Valda Richters, Richard Sposto, A novel snake venom disintegrin that inhibits human ovarian cancer dissemination and angiogenesis in an orthotopic nude mouse model. Haemostasis. ,vol. 31, pp. 183- 191 ,(2001) , 10.1159/000048062
Qing Zhou, Marian T. Nakada, Peter C. Brooks, Stephen D. Swenson, Matthew R. Ritter, Svetlana Argounova, Catherine Arnold, Francis S. Markland, Contortrostatin, a Homodimeric Disintegrin, Binds to Integrin αvβ5 Biochemical and Biophysical Research Communications. ,vol. 267, pp. 350- 355 ,(2000) , 10.1006/BBRC.1999.1965
Martin Gleave, Hideaki Miyake, Kim Chi, Beyond simple castration: targeting the molecular basis of treatment resistance in advanced prostate cancer Cancer Chemotherapy and Pharmacology. ,vol. 56, pp. 47- 57 ,(2005) , 10.1007/S00280-005-0098-0
Andreas Erbersdobler, Hendrik Isbarn, Kira Dix, Isabel Steiner, Thorsten Schlomm, Martina Mirlacher, Guido Sauter, Alexander Haese, Prognostic value of microvessel density in prostate cancer: a tissue microarray study World Journal of Urology. ,vol. 28, pp. 687- 692 ,(2010) , 10.1007/S00345-009-0471-4
Jian-Ping Xiong, Thilo Stehle, Simon L. Goodman, M. Amin Arnaout, New insights into the structural basis of integrin activation Blood. ,vol. 102, pp. 1155- 1159 ,(2003) , 10.1182/BLOOD-2003-01-0334
R.J.A van Moorselaar, E.E Voest, Angiogenesis in prostate cancer: its role in disease progression and possible therapeutic approaches Molecular and Cellular Endocrinology. ,vol. 197, pp. 239- 250 ,(2002) , 10.1016/S0303-7207(02)00262-9